Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.

The c-rel proto-oncogene, which is expressed predominantly in hemopoietic cells encodes a subunit of the NF-kappa B-like family of transcription factors. In mice with an inactivated c-rel gene, whereas development of cells from all hemopoietic lineages appeared normal, humoral immunity was impaired and mature B and T cells were found to be unresponsive to most mitogenic stimuli. Phorbol ester and calcium ionophore costimulation, in contrast to certain membrane receptor-mediated signals, overcame the T cell-proliferative defect, demonstrating that T cell proliferation occurs by Rel-dependent and -independent mechanisms. The ability of exogenous interleukin-2 to restore T Cell, but not B cell, proliferation indicates that Rel regulates the expression of different genes in B and T cells that are crucial for cell division and immune function.

[1]  M. Arsura,et al.  Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line , 1995, The Journal of experimental medicine.

[2]  David Baltimore,et al.  Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.

[3]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[4]  T. Tan,et al.  Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells , 1994, Molecular and cellular biology.

[5]  L. Corcoran,et al.  Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation. , 1994, Immunity.

[6]  D. Carrasco,et al.  Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. , 1994, Oncogene.

[7]  Y. Hitoshi,et al.  Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells , 1994, The Journal of experimental medicine.

[8]  B. Kistler,et al.  Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. , 1994, The EMBO journal.

[9]  D. Baltimore,et al.  Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation , 1994 .

[10]  D. Baltimore,et al.  Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. , 1994, Molecular and cellular biology.

[11]  I. Verma,et al.  Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Hrdličková,et al.  v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel , 1994, Journal of virology.

[13]  B. Vandenbunder,et al.  C-Rel: a multifunctional transcription factor ? , 1994, Cell death and differentiation.

[14]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[15]  G. Crabtree,et al.  Signal transmission between the plasma membrane and nucleus of T lymphocytes. , 1994, Annual review of biochemistry.

[16]  B. Vandenbunder,et al.  High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro , 1993, Cell.

[17]  M. Levine,et al.  Dif, a dorsal-related gene that mediates an immune response in Drosophila , 1993, Cell.

[18]  R. Zinkernagel,et al.  Immune responses in interleukin-2-deficient mice. , 1993, Science.

[19]  Y. Ben-Neriah,et al.  Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB , 1993, Nature.

[20]  S. Gerondakis,et al.  rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  M. Harbers,et al.  Identification and analysis of all components of a gel retardation assay by combination with immunoblotting. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Olive,et al.  Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  W C Greene,et al.  NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.

[24]  C. Stewart,et al.  Simple screening procedure to detect gene targeting events in embryonic stem cells. , 1993, Methods in enzymology.

[25]  M. Grilli,et al.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.

[26]  G. Nossal,et al.  Functional and molecular characterization of single, (4‐hydroxy‐3‐nitrophenyl)acetyl (NP)‐specific, IgG1+ B cells from antibody‐secreting and memory B cell pathways in the C57BL/6 immune response to NP , 1992, European journal of immunology.

[27]  M. Karin,et al.  Molecular Cloning and Characterization of a Novel Rel/NF-χB Family Member Displaying Structural and Functional Homology to NF-χB p50/p105 , 1992 .

[28]  D. Longo,et al.  Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel , 1992, Molecular and cellular biology.

[29]  G. Nolan,et al.  The inhibitory ankyrin and activator Rel proteins , 1992, Current Biology.

[30]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[31]  P. Kourilsky,et al.  The characterization of the promoter of the gene encoding the p50 subunit of NF‐kappa B indicates that it participates in its own regulation. , 1992, The EMBO journal.

[32]  J. W. Rooney,et al.  Cross‐linking of surface IgM activates NF‐xB in B lymphocyte , 1991 .

[33]  Suzanne Cory,et al.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.

[34]  M. Rudnicki,et al.  The mouse Pgk-1 gene promoter contains an upstream activator sequence. , 1991, Nucleic acids research.

[35]  T. Gilmore.  Malignant transformation by mutant Rel proteins. , 1991, Trends in genetics : TIG.

[36]  Gary J. Nabel,et al.  Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65 , 1991, Nature.

[37]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[38]  P. Richardson,et al.  vRel is an inactive member of the Rel family of transcriptional activating proteins , 1991, Journal of virology.

[39]  T. Hunter,et al.  c-rel activates but v-rel suppresses transcription from kappa B sites. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Baeuerle.  The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[41]  H. Temin,et al.  Structure and autoregulation of the c-rel promoter. , 1990, Oncogene.

[42]  W. Greene,et al.  The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function , 1990, Cell.

[43]  G. Nolan,et al.  Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal , 1990, Cell.

[44]  A. Israël,et al.  The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product , 1990, Cell.

[45]  D. Baltimore,et al.  Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" , 1990, Nature.

[46]  S. Gerondakis,et al.  The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli. , 1990, Oncogene research.

[47]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[48]  M. Siekevitz,et al.  Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. , 1989, Science.

[49]  B. Moore,et al.  Expression of the c-rel and c-myc proto-oncogenes in avian tissues. , 1989, Oncogene.

[50]  T. Hirano,et al.  Molecular regulation of B lymphocyte response. , 1988, Annual review of immunology.

[51]  R. Steward.  Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel. , 1987, Science.

[52]  J. Bluestone,et al.  Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[54]  D. Metcalf.  Role of mercaptoethanol and endotoxin in stimulating B lymphocyte colony formation in vitro. , 1976, Journal of immunology.

[55]  Mutual regulation of the transcriptional activator NF-cB and its inhibitor, I1cB-a , 2022 .